|
1
|
Ljungberg B, Campbell SC, Choi HY, Jacqmin
D, Lee JE, Weikert S and Kiemeney LA: The epidemiology of renal
cell carcinoma. Eur Urol. 60:615–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of clear cell renal cell
carcinoma. Nature. 499:43–49. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geisler S and Coller J: RNA in unexpected
places: Long non-coding RNA functions in diverse cellular contexts.
Nat Rev Mol Cell Biol. 14:699–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hajjari M and Salavaty A: HOTAIR: An
oncogenic long non-coding RNA in different cancers. Cancer Biol
Med. 12:1–9. 2015.PubMed/NCBI
|
|
9
|
Hirata H, Hinoda Y, Shahryari V, Deng G,
Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long Noncoding RNA
MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and
Interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han Y, Liu Y, Nie L, Gui Y and Cai Z:
Inducing cell proliferation inhibition, apoptosis, and motility
reduction by silencing long noncoding ribonucleic acid
metastasis-associated lung adenocarcinoma transcript 1 in
urothelial carcinoma of the bladder. Urology. 81:209.e1–209.e7.
2013. View Article : Google Scholar
|
|
11
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Serghiou S, Kyriakopoulou A and Ioannidis
JPA: Long noncoding RNAs as novel predictors of survival in human
cancer: A systematic review and meta-analysis. Mol Cancer.
15:502016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen SX, Yin JF, Lin BC, Su HF, Zheng Z,
Xie CY and Fei ZH: Upregulated expression of long noncoding RNA
SNHG15 promotes cell proliferation and invasion through regulates
MMP2/MMP9 in patients with GC. Tumour Biol. 37:6801–6812. 2016.
View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
von Roemeling CA, Radisky DC, Marlow LA,
Cooper SJ, Grebe SK, Anastasiadis PZ, Tun HW and Copland JA:
Neuronal pentraxin 2 supports clear cell renal cell carcinoma by
activating the AMPA-selective glutamate receptor-4. Cancer Res.
74:4796–4810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Julien S, Puig I, Caretti E, Bonaventure
J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A
and Larue L: Activation of NF-kappaB by Akt upregulates Snail
expression and induces epithelium mesenchyme transition. Oncogene.
26:7445–7456. 2007. View Article : Google Scholar
|
|
17
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar
|
|
18
|
Criswell TL and Arteaga CL: Modulation of
NFkappaB activity and E-cadherin by the type III transforming
growth factor beta receptor regulates cell growth and motility. J
Biol Chem. 282:32491–32500. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
She K, Huang J, Zhou H, Huang T, Chen G
and He J: lncRNA-SNHG7 promotes the proliferation, migration and
invasion and inhibits apoptosis of lung cancer cells by enhancing
the FAIM2 expression. Oncol Rep. 36:2673–2680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang T, Ji Y, Hu D, Chen B, Zhang H, Li
C, Chen G, Luo X, Zheng XW and Lin X: SNHG8 is identified as a key
regulator of epstein-barr virus(EBV)-associated gastric cancer by
an integrative analysis of lncRNA and mRNA expression. Oncotarget.
7:80990–81002. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Christensen LL, True K, Hamilton MP,
Nielsen MM, Damas ND, Damgaard CK, Ongen H, Dermitzakis E, Bramsen
JB, Pedersen JS, et al: SNHG16 is regulated by the Wnt pathway in
colorectal cancer and affects genes involved in lipid metabolism.
Mol Oncol. 10:1266–1282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai C, Huo Q, Wang X, Chen B and Yang Q:
SNHG16 contributes to breast cancer cell migration by competitively
binding miR-98 with E2F5. Biochem Biophys Res Commun. 485:272–278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qi X, Shao M, Sun H, Shen Y, Meng D and
Huo W: Long non-coding RNA SNHG14 promotes microglia activation by
regulating miR-145-5p/PLA2G4A in cerebral infarction. Neuroscience.
348:98–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang O, Yang F, Liu Y, Lv L, Ma R, Chen C,
Wang J, Tan Q, Cheng Y, Xia E, et al: C-MYC-induced upregulation of
lncRNA SNHG12 regulates cell proliferation, apoptosis and migration
in triple-negative breast cancer. Am J Transl Res. 9:533–545.
2017.PubMed/NCBI
|
|
26
|
Zhang JH, Wei HW and Yang HG: Long
noncoding RNA SNHG15, a potential prognostic biomarker for
hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 20:1720–1724.
2016.PubMed/NCBI
|
|
27
|
Tani H and Torimura M: Identification of
short-lived long non-coding RNAs as surrogate indicators for
chemical stress response. Biochem Biophys Res Commun. 439:547–551.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Escárcega RO, Fuentes-Alexandro S,
García-Carrasco M, Gatica A and Zamora A: The transcription factor
nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol).
19:154–161. 2007. View Article : Google Scholar
|
|
29
|
Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X,
Lin L, Yao H, Su F, Li D, et al: A cytoplasmic NF-κB interacting
long noncoding RNA blocks IκB phosphorylation and suppresses breast
cancer metastasis. Cancer Cell. 27:370–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Özeş AR, Miller DF, Özeş ON, Fang F, Liu
Y, Matei D, Huang T and Nephew KP: NF-κB-HOTAIR axis links DNA
damage response, chemoresistance and cellular senescence in ovarian
cancer. Oncogene. 35:5350–5361. 2016. View Article : Google Scholar
|
|
31
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu L, Mu Y, Sa N, Wang H and Xu W: Tumor
necrosis factor α induces epithelial-mesenchymal transition and
promotes metastasis via NF-κB signaling pathway-mediated TWIST
expression in hypopharyngeal cancer. Oncol Rep. 31:321–327. 2014.
View Article : Google Scholar
|
